Intra-Cellular Therapies
ITCI
#1819
Rank
C$12.62 B
Marketcap
$119.08
Share price
-0.41%
Change (1 day)
48.16%
Change (1 year)

Revenue for Intra-Cellular Therapies (ITCI)

Revenue in 2024 (TTM): C$0.82 Billion

According to Intra-Cellular Therapies's latest financial reports the company's current revenue (TTM ) is C$0.85 Billion. In 2023 the company made a revenue of C$0.61 Billion an increase over the revenue in the year 2022 that were of C$0.33 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intra-Cellular Therapies from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) C$0.82 B35.08%
2023 C$0.61 B81.33%
2022 C$0.33 B224.65%
2021 C$0.10 B262.47%
2020 C$28.72 M36189.49%
2019 C$0.07 M
2018 N/A
2017 N/A
2016 N/A-100%
2015 C$0.04 M-93.31%
2014 C$0.63 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$1.39 M-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.18 M-98.34%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.18 B-78.19%๐Ÿ‡บ๐Ÿ‡ธ USA